About this trial
The purpose of this multicenter randomized non-inferiority trial is to evaluate the safety of low anterior resection for rectal cancer performed with versus without a diverting stoma in patients with a low predicted risk of colorectal anastomotic leakage.
The primary objective is to determine whether the rate of anastomotic leakage within 30 days after surgery in the no-stoma group is non-inferior to that in the diverting stoma group.
The secondary objectives include comparison between groups regarding: Stoma rate at 1 year after surgery; Quality of life at 30 days and 1 year (EORTC QLQ-C30, EORTC QLQ-CR29, and LARS score); Short-term postoperative outcomes, including postoperative day metrics, length of hospital stay, and complications graded according to the Clavien-Dindo classification; Reoperation rates within 30 days and 1 year.
Participants will include adult patients with mid- or low-rectal adenocarcinoma who are scheduled for radical minimally invasive total mesorectal excision and have a predicted risk of anastomotic leakage \<10% according to the study risk model.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >18 years;
Primary rectal cancer staged as cT1-4aN0-3M0 (or ycT0-4aN0-2M0);
Histologically confirmed rectal adenocarcinoma based on endoscopic biopsy;
Tumor located ≤12 cm from the dentate line (based on endoscopy, digital rectal examination, and/or pelvic MRI);
Disqualifiers
Age ≥80 years;
Presence of a pre-existing diverting ileostomy or colostomy;
Peritumoral abscess or tumor perforation;
Distant metastases (M1) identified preoperatively and/or intraoperatively;
Trial design
Parallel
Treatments tested in this trial
Without a preventive stoma
Procedure/SurgeryAt the conclusion of total mesorectal excision (TME), a diverting ileostomy or transverse colostomy will be created at the discretion of the operating surgeon. The pelvic peritoneum over the anastomotic site will be closed, and a pelvic drain will be placed (the type of drain will be determined by the operating surgeon).
With a preventive stoma
Procedure/SurgeryThe operating surgeon will follow the standard practice adopted at the respective center and will create either a diverting ileostomy or transverse colostomy at their discretion. The pelvic peritoneum will not be closed. Placement of a percutaneous pelvic drain adjacent to the anastomotic site is mandatory.
Treatment groups
Trial outcomes
Primary outcomes
Colorectal anastomotic leak
If anastomotic leakage is suspected in the postoperative period defined by worsening abdominal pain (\>5-point increase on the Visual Analog Scale), signs of peritonitis, drain output containing fibrin or intestinal content, or radiologic findings suggestive of leakage on contrast-enhanced CT of the abdomen and pelvis (with or without proctography) and/or findings at diagnostic laparoscopy. Diagnostic and/or therapeutic measures will be undertaken to confirm or rule out the complication.
Secondary outcomes
Postoperative complications
Postoperative complications will be classified according to the Clavien-Dindo classification
Reoperation rate
During a clinic visit or by telephone interview
Stoma rate
During a clinic visit or by telephone interview
Hospital readmissions
The frequency of repeated admissions to this or other hospitals after the patient's discharge
Sponsors and contacts
Click on the lead sponsor to view all of their trials.